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and an infant may likewise present with bleeding diathesis; pruritis; deficiency of vitamins A, D, E, K; and failure to thrive. Besides these general symptoms, there are specific clinical features depending on the cause. Coagulopathy may be caused by vitamin K deficiency, liver failure, or severe metabolic derangement of the liver (as in neonatal hemochromatosis). Splenomegaly can be seen in infants who have cirrhosis and portal hypertension, intrauterine infections, storage diseases, and hemolytic disorders such as Rh-isoimmunization. Neurologic abnormalities including irritability, lethargy, poor feeding, hypotonia, or seizures can indicate sepsis, intracranial hemorrhage, metabolic (including Zellweger syndrome) and mitochondrial disorders, or severe liver dysfunction resulting in hyperammonemia and encephalopathy. Low birth weight, thrombocytopenia, petechiae and purpura, and chorioretinitis are regularly associated with intrauterine infections. Congenital infections may also be associated with rash, microcephaly, intrauterine growth restriction, and intracranial calcification. Facial dysmorphism may suggest a chromosomal abnormality or Alagille syndrome. An obvious mass in the upper quadrant of the abdomen may indicate a choledochal cyst. A cardiac murmur increases the likelihood of Alagille syndrome or biliary atresia. On physical examination, infants with biliary atresia are generally thriving well and are appearing well except for jaundice, and stools are often acholic. However, biliary atresia may present with features of advanced liver disease such as ascites and hepatosplenomegaly if there is a delay in diagnosis. By contrast, infants with infectious and metabolic cause appear sick and have inadequate weight gain. 8 A peculiar odor of body or urine may point to a metabolic cause. Examination of male genitalia and ability to fix and follow a moving object may be useful clues for panhypopituitarism and septo-optic dysplasia, respectively.
Etiology
A myriad of potential causes have been identified causing NC and this list is ever increasing with improvement and upgradation of diagnostics and laboratory services. Causes of NC can be broadly divided into surgical and medical causes. Overall biliary atresia is the most common identifiable cause of NC. [7] [8] [9] [10] [11] [12] [13] [14] According to a latest published metaanalysis comprising 17 studies encompassing 1692 infants, idiopathic neonatal hepatitis was observed in 26%, extrahepatic biliary atresia in 26%, infection in 12%, TPNassociated cholestasis in 6.5%, metabolic disease in 4.37%, α 1 -antitrypsin deficiency in 4.14%, and perinatal hypoxia/ ischemia in 4% of infants with NC. Among the infections and metabolic disorders, cytomegalovirus (CMV ) and galactosemia (37% of metabolic disorders) were the most common identifiable causes, respectively. 11 Lack of uniform protocol for diagnosing NC was the main drawback of study (Table 1) .
Diagnostic Approach
Joint recommendation by the North American Society for Pediatric Gastroenterology, 3, 8, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition 2016, has defined abnormal direct/conjugated bilirubin as a serum value >1.0 mg/ dL (17 mmol/L), because it is physiologically and clinically complex to consider incorporating consideration of whether or not the direct fraction exceeds 20% of the total bilirubin level as mentioned in some publications. 14 In cases of preterm and small for gestation, with a negative septic and metabolic screen and a normal ultrasound abdomen, a close observation period till the corrected age of 40 weeks or weight of 2.5 kg can be considered, respectively. Commonly employed investigations in a patient of NC are given in Table 2 . The aim of the evaluation is to look for treatable causes at the earliest and start specific treatment as appropriate depending on history and clinical evaluation. In general, hepatocellular etiology or hepatitis is associated with a rise in liver enzymes and extrahepatic causes are associated with rise in γ-glutamyl transpeptidase with few exceptions. To access the hepatocellular damage, one needs to do a serum albumin and coagulation profile (prothrombin time, international normalized ratio). Common treatable causes of NC include sepsis (bacterial; viral; CMV, HSV; fungal; etc), thyroid disorder, galactosemia, and hemochromatosis.
We provide a schematic diagram to work up a patient of NC syndrome in Figure 2 . All patients with age more than 60 days who have previously been admitted and have still not being diagnosed should be referred to a tertiary center with facility for liver transplant for optimal management.
Role of Genomics in the evaluation of NC: Genetic Cholestasis
Use of genomics especially whole-genome sequencing (WGS/ WES) and next-generation sequencing has an increasing role in the diagnosis of rare disorders in ill neonates and has the potential to augment or modify the care of this vulnerable population of patients. 36 However, cost, interpretation of results and availability are the major obstacles in ordering these investigations. Nevertheless, genomics has made the biggest impact in neonatology than any other specialties of medicine. In addition, the advantage of diagnosis in antenatal period cannot be ignored. Keeping the above constrains in mind, targeted genomics is the need of the hour. Targeted genetic testing represents a multitiered approach offered either presymptomatically or postsymptomatically. Presymptomatic testing is offered to individuals with a known genetic disorder in the family, whereas postsymptomatic genetic testing should be offered to individuals suspected clinically to be affected by genetic disease, ranging from gene specific to panel specific to WGS/ WES. 37 Some of the disorders which can be unveiled with • Triangular cord sign (triangular echogenic area due to fibrous tissue at the porta hepatis), small (<15 mm) or nonvisualization of the gallbladder, lack of gallbladder contraction after oral feeding are suggestive of biliary atresia • To establish diagnosis of choledochal cyst • To look for complications such as ascites, portal hypertension, intraventricular bleed, and associated malformation like polysplenia 8. Urine for reducing substances and galactose-1-phosphate uridylyltransferase levels
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• Measured by spectrophotometry (normal levels: 11-41 U/g hb) 9 . hepatobiliary scintigraphy using Technetium-99m-labeled iminodiacetic acid (hIDA scan) ¾ Sensitivity 98.7% ¾ Specificity 70.4% ¾ Single photon emission computer tomography (SPECT) can improve the specificity (81.1%) ¾ Gastrointestinal and duodenal fluid sampling increases the specificity to 73.2% and 77.1%, respectively ¾ high rates of false positive in interlobular bile duct paucity, idiopathic neonatal hepatitis, low birth weight, and those on total parenteral nutrition neonates
• Requires controversial pretreatment with phenobarbitone (5 mg/kg/d) for at least 3-5 days for best results. Serial images to be taken for up to 24 h or until the gut activity are visualized. Suggestive of biliary atresia or severe hepatocellular dysfunction if there is nonvisualization of the radioisotope in the small intestine. however, if there is a slow uptake of the radioisotope or nonvisualization of the liver, it suggests hepatocellular dysfunction • Only a supportive investigation should only be done when available in the same center, otherwise should not be done as it may result in wastage of crucial time, money, and resources • Best use is to exclude biliary atresia 10. Liver biopsy for diagnosis and prognosis depending on the extent of fibrosis ¾ Sensitivity for biliary atresia: >95% ¾ Specificity for biliary atresia >94% ¾ Features suggestive of biliary atresia include 9 bile duct proliferation, bile plugs 9 Portal tract edema and fibrosis 9 with preservation of the basic hepatic lobular architecture
• Useful for biliary atresia, α 1 -antitrypsin deficiency, Alagille syndrome, neonatal sclerosing cholangitis, cytomegalovirus, and herpes simplex infections ¾ Avoid early biopsy, may lead to false-negative results, repeat when in doubt ¾ histologic mimics of biliary atresia include cystic fibrosis, PNALD, and α 1 -antitrypsin deficiency 11. α 1 -antitrypsin phenotype (Pi typing) and level ¾ PI analysis (type ZZ, SZ, MZ)
Levels are usually confusing with high false-positive and false-negative rates. Pi testing is useful 12. x-ray chest and spine To look for associated anomalies associated with biliary atresia and Alagille syndrome (20%-30%) especially in the presence of a murmur 13. Alpha-feto (AFP) protein levels and urine for succinyl acetone
• AFP levels although nonspecific are markedly raised in tyrosinemia
• Urine for succinyl acetone should be done in a freshly passed urine sample. Delay in processing may increase false-negative rates
PCR (blood and/or CSF)
• CMV, hSV, Listeria 
Conclusions
Neonatal cholestasis must be considered in any infant presenting with prolonged jaundice longer than 2 weeks or early if associated with hepatomegaly, failure to thrive, acholic stools, or dark urine. Neonatal cholestasis, although rare, is a lifethreatening condition unless timely diagnosed and managed appropriately. However, delay in diagnosis of NC, particularly of biliary atresia, remains a problem. Misinterpretation with physiological jaundice, lack of national-level screening programs for inborn errors of metabolism, and presence of pigmented stools are often the cause of delay in diagnosis. Universal screening for NC still has a long way to go. There is a need for strict follow-up, use of stool card, and awareness. *Workup includes sweat chloride, Pi typing, serum cortisol, urine GCMS, TMS, acyl carnitine profile, ANA, anti-Ro/SSA, anti-La/SSB, anti-U1RNP antibodies, urinary bile acid analysis, genetic analysis for PFIC (↑ liver enzymes and ↓ GGT) and bone marrow for hemophagocytic lymphohistiocytosis (hLh). Diagnostic criteria for hLh includes fever (>7 days), hepatosplenomegaly with liver dysfunction, pancytopenia, sCD25 (>2400 μg/mL), ferritin (>500 μg/L), triglycerides (>3 mmol/L), hypofibrinogenemia (<150 mg/dL), and serum cytokine levels of both IFNγ (>75 pg/mL) and IL-10 (>60 pg/mL) ↑. 36, 37, 42, 43 6
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Even if there is no specific management, appropriate supportive care and nutritional rehabilitation may be life-saving in most cases of NC.
